NCT01296802View on ClinicalTrials.gov

Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Amphetamine-Related DisordersAmphetamine Abuse
Interventions
DRUG

dexfenfluramine

oral, 40 mg to 60 mg, single application as a challenge

Trial Locations (1)

8032

University Hospital of Psychiatry Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT01296802 - Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging | Biotech Hunter | Biotech Hunter